Skip to main content

Table 5 The association between MAD2L1 and LUSC clinical pathological features

From: Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development

parameters MAD2L1 P value
+
Gender P = 0.097
male 170 (47.8%) 186 (52.2%)
female 71 (56.3%) 55 (43.7%)
Age P = 0.100
< 60 years old 44 (42.7%) 59 (57.3%)
≥ 60 years old 192 (51.9%) 178 (48.1%)
Smoke P = 0.973
 no 131 (50.6%) 128 (49.4%)
 Smoker < 15 years 28 (50.0%) 28 (50.0%)
 Smoker ≥15 years 82 (49.4%) 84 (50.6%)
Stage P = 0.062
 I 132 (56.2%) 103 (43.8%)
 II 70 (44.6%) 87 (55.4%)
 III 35 (42.7%) 47 (57.3%)
 IV 4 (57.1%) 3 (42.9%)
T P = 0.314
 I 60 (56.1%) 47 (43.9%)
 II 131 (46.5%) 151 (53.5%)
 III 38 (54.3%) 32 (45.7%)
 IV 12 (52.2%) 11 (47.8%)
N P = 0.001
 - 171 (55.9%) 135 (44.1%)
 + 70 (39.8%) 106 (60.2%)
M P = 0.036
 - 188 (48.0%) 204 (52.0%)
 + 52 (60.5%) 34 (39.5%)